Ammar Abdulrahman Jairoun
Ammar Abdulrahman Jairoun publishes mostly in Public Health, Environmental and Occupational Health, Epidemiology and Geriatrics and Gerontology, on topics such as Pharmaceutical Practices and Patient Outcomes, Antibiotic Use and Resistance and Diabetes, Cardiovascular Risks, and Lipoproteins.
- World rank
- #178,732 of 7,710,434 ranked researchers
- Rank in United Arab Emirates
- #205 of 6,273
- Works
- 219
- Citations
- 25k
- Citations per work
- 115.7
What does Ammar Abdulrahman Jairoun research?
Ammar Abdulrahman Jairoun's work is mostly in Medicine (19%), Immunology and Microbiology (4%), Health Professions (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else16072.9%
- Health Sciences5022.9%
- Medicine4219.0%
- Health Professions93.9%
- Life Sciences94.2%
- 1Public Health, Environmental and Occupational Health5% of their works
- 2Epidemiology5% of their works
- 3Geriatrics and Gerontology5% of their works
- 4Applied Microbiology and Biotechnology4% of their works
- 5Infectious Diseases4% of their works
- 6General Health Professions4% of their works
Research topics
- Pharmaceutical Practices and Patient Outcomes
- Antibiotic Use and Resistance
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pharmaceutical Quality and Counterfeiting
- Medication Adherence and Compliance
- Pharmaceutical Economics and Policy
- COVID-19 epidemiological studies
- Liver Disease Diagnosis and Treatment
Which keywords describe Ammar Abdulrahman Jairoun's research?
The keywords of their largest research topics: Epidemiology, Infectious Diseases, Inappropriate Medication Use, Polypharmacy, Antibiotic Resistance, Antimicrobial Stewardship, Insulin Resistance and Metabolic Syndrome.
- NASH
- Modeling
- Treatment Adherence
- Generic Drugs
- Substandard Medicines
- Diabetes
- Metabolic Syndrome
- Antimicrobial Stewardship
- Polypharmacy
- Infectious Diseases
- Epidemiology
- Inappropriate Medication Use
- Antibiotic Resistance
- Insulin Resistance
- Cardiovascular Disease
- Counterfeit Drugs
- Drug Development Costs
- Medication Adherence
- COVID-19
- NAFLD
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Epidemiology332 topics
- Infectious Diseases332 topics
- Inappropriate Medication Use291 topic
- Polypharmacy291 topic
- Antibiotic Resistance261 topic
- Antimicrobial Stewardship261 topic
- Insulin Resistance172 topics
- Metabolic Syndrome172 topics
- Cardiovascular Disease101 topic
- Diabetes101 topic
- Counterfeit Drugs91 topic
- Substandard Medicines91 topic
- Drug Development Costs81 topic
- Generic Drugs81 topic
- Medication Adherence81 topic
- Treatment Adherence81 topic
- COVID-1971 topic
- Modeling71 topic
- NAFLD71 topic
- NASH71 topic
Where does Ammar Abdulrahman Jairoun work?
Ammar Abdulrahman Jairoun's main affiliation in the publication record is Ajman University, United Arab Emirates.
How many publications and citations does Ammar Abdulrahman Jairoun have?
OpenAlex counts 219 works and 25,345 citations for Ammar Abdulrahman Jairoun, an h-index of 44, ranking #178,732 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Ammar Abdulrahman Jairoun
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ammar Abdulrahman Jairoun. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.